225 related articles for article (PubMed ID: 31572388)
1. The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype.
Cuff AO; Sillito F; Dertschnig S; Hall A; Luong TV; Chakraverty R; Male V
Front Immunol; 2019; 10():2180. PubMed ID: 31572388
[TBL] [Abstract][Full Text] [Related]
2. Increased Frequency of Dysfunctional Siglec-7
Sakamoto Y; Yoshio S; Doi H; Mori T; Matsuda M; Kawai H; Shimagaki T; Yoshikawa S; Aoki Y; Osawa Y; Yoshida Y; Arai T; Itokawa N; Atsukawa M; Ito T; Honda T; Mise Y; Ono Y; Takahashi Y; Saiura A; Taketomi A; Kanto T
Front Immunol; 2021; 12():603133. PubMed ID: 33692781
[TBL] [Abstract][Full Text] [Related]
3. Natural Killer Cells and Type 1 Innate Lymphoid Cells Are New Actors in Non-alcoholic Fatty Liver Disease.
Luci C; Vieira E; Perchet T; Gual P; Golub R
Front Immunol; 2019; 10():1192. PubMed ID: 31191550
[TBL] [Abstract][Full Text] [Related]
4. Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver Disease.
Stiglund N; Strand K; Cornillet M; Stål P; Thorell A; Zimmer CL; Näslund E; Karlgren S; Nilsson H; Mellgren G; Fernø J; Hagström H; Björkström NK
Front Immunol; 2019; 10():1255. PubMed ID: 31214196
[TBL] [Abstract][Full Text] [Related]
5. Interplay Between Liver Type 1 Innate Lymphoid Cells and NK Cells Drives the Development of Alcoholic Steatohepatitis.
Cheng C; Zhang Q; Li Y; Jiang J; Xie L; Shen H; Wu D; Zhang H; Zhang H; Wang X; Wu H; Xu J; Gui L; Li B; Ju C; Peng H; Yin S; Xu L
Cell Mol Gastroenterol Hepatol; 2023; 15(1):261-274. PubMed ID: 36174925
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the immune cell landscape of patients with NAFLD.
Diedrich T; Kummer S; Galante A; Drolz A; Schlicker V; Lohse AW; Kluwe J; Eberhard JM; Schulze Zur Wiesch J
PLoS One; 2020; 15(3):e0230307. PubMed ID: 32168345
[TBL] [Abstract][Full Text] [Related]
7. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
8. Liver immune responses to inflammatory stimuli in a diet-induced obesity model of zebrafish.
Forn-Cuní G; Varela M; Fernández-Rodríguez CM; Figueras A; Novoa B
J Endocrinol; 2015 Feb; 224(2):159-70. PubMed ID: 25371540
[TBL] [Abstract][Full Text] [Related]
9. iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling.
Deng X; Wang J; Jiao L; Utaipan T; Tuma-Kellner S; Schmitz G; Liebisch G; Stremmel W; Chamulitrat W
Biochim Biophys Acta; 2016 May; 1861(5):449-61. PubMed ID: 26873633
[TBL] [Abstract][Full Text] [Related]
10. Development, Homeostasis, and Heterogeneity of NK Cells and ILC1.
Seillet C; Belz GT; Huntington ND
Curr Top Microbiol Immunol; 2016; 395():37-61. PubMed ID: 26305047
[TBL] [Abstract][Full Text] [Related]
11. The Production of Pro-angiogenic VEGF-A Isoforms by Hypoxic Human NK Cells Is Independent of Their TGF-β-Mediated Conversion to an ILC1-Like Phenotype.
Hawke LG; Whitford MKM; Ormiston ML
Front Immunol; 2020; 11():1903. PubMed ID: 32983113
[TBL] [Abstract][Full Text] [Related]
12. Altered phenotype of NK cells from obese rats can be normalized by transfer into lean animals.
Lautenbach A; Wrann CD; Jacobs R; Müller G; Brabant G; Nave H
Obesity (Silver Spring); 2009 Oct; 17(10):1848-55. PubMed ID: 19444229
[TBL] [Abstract][Full Text] [Related]
13. Differential phenotypic and functional properties of liver-resident NK cells and mucosal ILC1s.
Tang L; Peng H; Zhou J; Chen Y; Wei H; Sun R; Yokoyama WM; Tian Z
J Autoimmun; 2016 Feb; 67():29-35. PubMed ID: 26422992
[TBL] [Abstract][Full Text] [Related]
14. Revisiting the Role of Natural Killer Cells in Non-Alcoholic Fatty Liver Disease.
Martínez-Chantar ML; Delgado TC; Beraza N
Front Immunol; 2021; 12():640869. PubMed ID: 33679803
[TBL] [Abstract][Full Text] [Related]
15. [Age-related changes of the function and amount of natural killer cells in the liver: experiment with mice].
Zhao P; Bai XF; Yue X; Chi Q; Liu JZ; Hao XS
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1710-3. PubMed ID: 16854328
[TBL] [Abstract][Full Text] [Related]
16. T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease.
Gebru YA; Gupta H; Kim HS; Eom JA; Kwon GH; Park E; Jeong JJ; Won SM; Sharma SP; Ganesan R; Kim DJ; Suk KT
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830072
[TBL] [Abstract][Full Text] [Related]
17. Granzyme A and CD160 expression delineates ILC1 with graded functions in the mouse liver.
Di Censo C; Marotel M; Mattiola I; Müller L; Scarno G; Pietropaolo G; Peruzzi G; Laffranchi M; Mazej J; Hasim MS; Asif S; Russo E; Tomaipitinca L; Stabile H; Lee SH; Vian L; Gadina M; Gismondi A; Shih HY; Mikami Y; Capuano C; Bernardini G; Bonelli M; Sozzani S; Diefenbach A; Ardolino M; Santoni A; Sciumè G
Eur J Immunol; 2021 Nov; 51(11):2568-2575. PubMed ID: 34347289
[TBL] [Abstract][Full Text] [Related]
18. Hepatic natural killer cells exclusively kill splenic/blood natural killer-resistant tumor cells by the perforin/granzyme pathway.
Vermijlen D; Luo D; Froelich CJ; Medema JP; Kummer JA; Willems E; Braet F; Wisse E
J Leukoc Biol; 2002 Oct; 72(4):668-76. PubMed ID: 12377935
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver disease.
Cepero-Donates Y; Lacraz G; Ghobadi F; Rakotoarivelo V; Orkhis S; Mayhue M; Chen YG; Rola-Pleszczynski M; Menendez A; Ilangumaran S; Ramanathan S
Cytokine; 2016 Jun; 82():102-11. PubMed ID: 26868085
[TBL] [Abstract][Full Text] [Related]
20. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
